Martin Mackay - 29 Jul 2021 Form 3 Insider Report for Rallybio Corp (RLYB)

Role
Chief Executive Officer, Director
Signature
By: /s/ Michael Greco, Attorney-in-Fact
Issuer symbol
RLYB
Transactions as of
29 Jul 2021
Net transactions value
$0
Form type
3
Filing time
29 Jul 2021, 19:34:21 UTC
Previous filing
12 Jan 2022
Next filing
04 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding RLYB Common Stock 272,609 29 Jul 2021 Direct
holding RLYB Common Stock 436,517 29 Jul 2021 See Footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RLYB Option (Right to Buy) 29 Jul 2021 Common Stock 160,000 $13.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of common stock are held directly by a limited liability company, of which Martin Mackay is the managing member. As a result, Dr. Mackay may be deemed to share beneficial ownership of the shares held by the limited liability company.
F2 The option vests as to 25% of the underlying shares of Common Stock on July 28, 2022 and as to the remaining 75% of the underlying shares of Common Stock in 36 equal monthly installments thereafter.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney